ARCHIVES

In Brief: Mary Lasker To Be Named To NIH Director’s Advisory Committee; Amos Appointment Official

This article is from The Cancer Letter archive.

Vol. 06 No. 29 | July 18, 1980

Download PDF Visit The Full Archive

Related Articles

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

February 24, 2006

NCI Forms Task Force To Examine Marin County Breast Cancer Incidence

November 15, 2002

DeVita takes Over As NCI Acing Director; Search Begins For New Permanent Chief

January 4, 1980

NCI Cooperative Group, Cancer Center Trials Listed

February 29, 2008

Phase III Kyprolis Trial Fails OS Primary Endpoint

August 29, 2014

NTP Panel Completed To Write New Testing, Evolution Guidelines

April 22, 1983